Bechdolf, A, Muller, H, Stutzer, H, Wagner, M, Maier, W, Lautenschlager, M, Heinz, A, de Millas, W, Janssen, B, Gaebel, W, Michel, TM, Schneider, F, Lambert, M, Naber, D, Brune, M, Kruger-Ozgurdal, S, Wobrock, T, Riedel, M, Klosterkotter, J and group, Ps (2011). Rationale and baseline characteristics of prevent: A second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophrenia Bulletin 37 Suppl 2, S111–S121.
Bechdolf, A, Müller, H, Stützer, H, Lambert, M, Karow, A, Zink, M, Lautenschlager, M, Heinz, A, de Millas, W, Janssen, B, Gaebel, W, Schneider, F, Juckel, G, Krüger-Özgürdal, S, Wobrock, T, Wagner, M, Maier, W and Klosterkötter, J (2017). 108. PREVENT: a randomized controlled trial for the prevention of first-episode psychosis comparing cognitive–behavior therapy (CBT), clinical management, and aripiprazole combined and clinical management and placebo combined. Schizophrenia Bulletin 43, S56–S57.
Bighelli, I, Salanti, G, Huhn, M, Schneider-Thoma, J, Krause, M, Reitmeir, C, Wallis, S, Schwermann, F, Pitschel-Walz, G, Barbui, C, Furukawa, TA and Leucht, S (2018). Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry 17, 316–329.
Birchwood, M and Trower, P (2006). The future of cognitive–behavioural therapy for psychosis: not a quasi-neuroleptic. The British Journal of Psychiatry 188, 107–108.
Birchwood, M, Michail, M, Meaden, A, Tarrier, N, Lewis, S, Wykes, T, Davies, L, Dunn, G and Peters, E (2014). Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. The Lancet Psychiatry 1, 23–33.
Burns, AMN, Erickson, DH and Brenner, CA (2014). Cognitive-behavioral therapy for medication-resistant psychosis: a meta-analytic review. Psychiatric Services 65, 874–880.
Davies, C, Cipriani, A, Ioannidis, JPA, Radua, J, Stahl, D, Provenzani, U, McGuire, P and Fusar-Poli, P (2018). Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry 17, 196–209.
Freeman, D, Dunn, G, Startup, H, Pugh, K, Cordwell, J, Mander, H, Černis, E, Wingham, G, Shirvell, K and Kingdon, D (2015). Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis. The Lancet Psychiatry 2, 305–313.
Garety, PA, Fowler, DG, Freeman, D, Bebbington, P, Dunn, G and Kuipers, E (2008). Cognitive–behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. The British Journal of Psychiatry 192, 412–423.
Hutton, P and Taylor, PJ (2014). Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis. Psychological Medicine 44, 449–468.
Jauhar, S, McKenna, PJ, Radua, J, Fung, E, Salvador, R and Laws, KR (2014). Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. The British Journal of Psychiatry 204, 20–29.
Jones, C, Hacker, D, Cormac, I, Meaden, A and Irving, CB (2012). Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. The Cochrane Database of Systematic Reviews 4, CD008712.
Jones, C, Hacker, D, Meaden, A, Cormac, I, Irving, CB, Xia, J, Zhao, S, Shi, C and Chen, J (2018). Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. The Cochrane Database of Systematic Reviews 11, CD008712.
Klingberg, S, Wittorf, A, Meisner, C, Wölwer, W, Wiedemann, G, Herrlich, J, Bechdolf, A, Müller, BW, Sartory, G, Wagner, M, Kircher, T, König, H-H, Engel, C and Buchkremer, G (2010). Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE study, a multicenter, prospective, single-blind, randomised controlled clinical trial. Trials 11, 123.
Klingberg, S, Wölwer, W, Engel, C, Wittorf, A, Herrlich, J, Meisner, C, Buchkremer, G and Wiedemann, G (2011). Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophrenia Bulletin 37(Suppl. 2), S98–110.
Laws, KR, Darlington, N, Kondel, TK, McKenna, PJ and Jauhar, S (2018). Cognitive behavioural therapy for schizophrenia – outcomes for functioning, distress and quality of life: a meta-analysis. BMC psychology 6, 32.
Leichsenring, F and Steinert, C (2017). Is cognitive behavioral therapy the gold standard for psychotherapy?: the need for plurality in treatment and research. JAMA 318, 1323–1324.
Morrison, AP, French, P, Stewart, SL, Birchwood, M, Fowler, D, Gumley, AI, Jones, PB, Bentall, RP, Lewis, SW, Murray, GK, Patterson, P, Brunet, K, Conroy, J, Parker, S, Reilly, T, Byrne, R, Davies, LM and Dunn, G (2012). Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial. British Medical Journal 344, e2233.
Morrison, AP, Pyle, M, Gumley, A, Schwannauer, M, Turkington, D, MacLennan, G, Norrie, J, Hudson, J, Bowe, SE, French, P, Byrne, R, Syrett, S, Dudley, R, McLeod, HJ, Griffiths, H, Barnes, TRE, Davies, L and Kingdon, D, FOCUS trial group (2018). Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial. The Lancet Psychiatry 5, 633–643.
NICE (2009). Schizophrenia: Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (update). London: National Institute of Clinical Excellence.
NICE (2014). Psychosis and schizophrenia in adults: Treatment and management. National clinical guideline number 178. London: National Collaborating Centre for Mental Health/National Institute for Health and Care Excellence.
Rathod, S, Phiri, P and Kingdon, D (2010). Cognitive behavioral therapy for schizophrenia. The Psychiatric Clinics of North America 33, 527–536.
Schulz, KF and Grimes, DA (2002a). Allocation concealment in randomised trials: defending against deciphering. The Lancet 359, 614–618.
Schulz, KF and Grimes, DA (2002b). Sample size slippages in randomised trials: exclusions and the lost and wayward. The Lancet 359, 781–785.
SIGN (2013). 131 Management of schizophrenia.
Stain, HJ, Bucci, S, Baker, AL, Carr, V, Emsley, R, Halpin, S, Lewin, T, Schall, U, Clarke, V, Crittenden, K and Startup, M (2016). A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: the detection and evaluation of psychological therapy (DEPTh) trial. Schizophrenia Research 176, 212–219.
van der Gaag, M, Nieman, DH, Rietdijk, J, Dragt, S, Ising, HK, Klaassen, RMC, Koeter, M, Cuijpers, P, Wunderink, L and Linszen, DH (2012). Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophrenia Bulletin 38, 1180–1188.
van der Gaag, M, Valmaggia, LR and Smit, F (2014a). The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis. Schizophrenia Research 156, 30–37.
Velthorst, E, Koeter, M, van der Gaag, M, Nieman, DH, Fett, A-KJ, Smit, F, Staring, ABP, Meijer, C and de Haan, L (2015). Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression. Psychological Medicine 45, 453–465.
White, IR, Horton, NJ, Carpenter, J and Pocock, SJ (2011). Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 342, d40.